Global Demand for Generics Soaring! India leads the way in pharma exports for 2024 and has a 20% global market share in generics! Industry Experts connects buyers with reliable Indian contract manufacturers. We ensure access to high-quality generics and optimize production costs. #IndiaPharma #ContractManufacturing #GlobalSourcing #PharmaExports #GenericDrugs #IndianPharma #PharmaIndustry #ContractManufacturing #GlobalHealthcare #HealthcareSolutions #ExportGrowth #TradeOpportunities #SupplyChain #MedicineProduction #MadeInIndia #HealthcareInnovation #PharmaceuticalIndustry #GlobalMarket
Industry Experts’ Post
More Relevant Posts
-
Global Demand for Generics Soaring! India leads the way in pharma exports for 2024 and has a 20% global market share in generics! Industry Experts connects buyers with reliable Indian contract manufacturers. We ensure access to high-quality generics and optimize production costs. Contact us today to explore your options for sourcing high-quality products. https://lnkd.in/dr9BMYVv #IndiaPharma #ContractManufacturing #GlobalSourcing #PharmaExports #GenericDrugs #IndianPharma #PharmaIndustry #ContractManufacturing #GlobalHealthcare #HealthcareSolutions #ExportGrowth #TradeOpportunities #SupplyChain #MedicineProduction #MadeInIndia #HealthcareInnovation #PharmaceuticalIndustry #GlobalMarket
-
-
#TamilNadu boasts a diverse industrial landscape with 400+ #manufacturing companies excelling in bulk drugs, APIs, formulations, #healthcare equipment, and #medicaldevices. Explore more at https://lnkd.in/fqubx-K #StateFocus #InvestIndia #InvestInIndia #InvestInTamilNadu #Pharma Department for Promotion of Industry and Internal Trade Ministry of Commerce and Industry, Government of India NITI Aayog
-
-
Big Opportunity in Pharma Sector! 💊🚀 India's pharma sector is set to hit a $57 billion market size by FY25, with profit margins improving by 100-150 basis points. Here's why you should take notice: ✅ Domestic growth: 8-9% steady growth, consistent export growth of 6-7% ✅ US patent expirations (2024-28): A significant opportunity for generic drug companies ✅ New segments: Companies targeting booming markets like anti-obesity drugs, projected to reach $100 billion by 2030! Despite challenges, this sector is entering a strong growth phase. Research now and prepare your pharma portfolio! 💬 Comment below: Which pharma stock do you have in your portfolio? 👉 Follow us for more sector analysis! [Pharma sector, Healthcare, Indian Pharma Sector, Pharma growth, Indian Market, Market Insights] #pharmastocks #pharmasector #indianpharma #stockmarket #smartinvesting #marketinsights #financialgrowth #wealthbuilding #choice #bharosekichoice
-
#TamilNadu boasts a diverse industrial landscape with 400+ #manufacturing companies excelling in bulk drugs, APIs, formulations, #healthcare equipment, and #medicaldevices. Explore more at https://lnkd.in/fqubx-K #StateFocus #InvestIndia #InvestInIndia #InvestInTamilNadu #Pharma Department for Promotion of Industry and Internal Trade Ministry of Commerce and Industry, Government of India NITI Aayog
-
-
Senior Sales Manager at Rubix Data Sciences Private Limited specializing in Enterprise Sales
India's Pharma Industry Soaring! Our latest Rubix Industry Insights explores why India has become the “Pharmacy of the World”. Read more for insights on domestic growth, exports & future potential. #RubixIndustryInsights #Insights #IndianIndustries #PharmaceuticalIndustry #PharmaIndustry #Pharma
We are excited to release the 2nd edition of Rubix Industry Insights, our monthly feature on key Indian industries. This edition is on the Pharmaceutical Industry, which is experiencing growth, fuelled by a surge in domestic demand and a booming export market. Our latest Rubix Industry Insights report delves into the key drivers propelling this double-digit growth. Uncover the secrets behind India's Pharma Success Story: - Domestic Demand on Fire: Explore how rising healthcare awareness and a growing population are driving a consumption boom within India. - Global Powerhouse in the Making: Is India the next "Pharmacy of the World"? Our report investigates India's impressive 60% share of the global vaccine market. - Beyond Generics: While generics are a major strength, we analyze the potential for India to become a leader in complex and specialty pharmaceuticals. - Navigating the Landscape: Gain insights into both the exciting opportunities and the challenges facing the Indian pharmaceutical sector, empowering you to make informed decisions. What’s more, this report has been featured in all print editions of Financial Express (India) You can check out the previous Rubix Industry Insights: Agrochemicals here: https://lnkd.in/dM4XrTcE Stay tuned for more industry insights and updates from Rubix Data Sciences! . . . . #RubixIndustryInsights #Insights #IndianIndustries #PharmaceuticalIndustry #PharmaIndustry #Pharma #Pharmacy #Agrochemicals
-
BioPharm International March 2024: Moving Biosimilars Forward in a Hesitant Market Despite a growing number of biosimilar approvals, market uptake remains a challenge. Read the issue here: https://lnkd.in/euWW3Gqi
-
🇨🇳 ➡️ 🇮🇳 𝐆𝐚𝐦𝐞 𝐂𝐡𝐚𝐧𝐠𝐞𝐫 : 𝐈𝐧𝐝𝐢𝐚'𝐬 𝐀𝐏𝐈 𝐒𝐞𝐥𝐟-𝐑𝐞𝐥𝐢𝐚𝐧𝐜𝐞 𝐃𝐫𝐢𝐯𝐞𝐬 𝐏𝐫𝐢𝐜𝐞 𝐂𝐫𝐚𝐬𝐡 💫Great news for the pharmaceutical industry. 𝐀𝐜𝐭𝐢𝐯𝐞 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐈𝐧𝐠𝐫𝐞𝐝𝐢𝐞𝐧𝐭 (𝐀𝐏𝐈) 𝐩𝐫𝐢𝐜𝐞𝐬 𝐚𝐫𝐞 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐢𝐧𝐠 𝐭𝐡𝐞𝐢𝐫 𝐛𝐢𝐠𝐠𝐞𝐬𝐭 𝐞𝐯𝐞𝐫 𝐝𝐫𝐨𝐩 𝐚𝐟𝐭𝐞𝐫 𝐂𝐨𝐯𝐢𝐝-19, bringing much-needed relief. ♦️𝐏𝐫𝐢𝐜𝐞𝐬 𝐝𝐨𝐰𝐧 50%: 𝐀𝐏𝐈 costs have fallen dramatically, leading to 𝐡𝐢𝐠𝐡𝐞𝐫 𝐩𝐫𝐨𝐟𝐢𝐭 𝐦𝐚𝐫𝐠𝐢𝐧𝐬 for pharma companies in the coming quarters. 👉𝐂𝐡𝐢𝐧𝐚 𝐟𝐚𝐜𝐭𝐨𝐫 :India's dependence on China for APIs had caused a surge in prices during Covid. This 𝐭𝐫𝐞𝐧𝐝 𝐡𝐚𝐬 𝐫𝐞𝐯𝐞𝐫𝐬𝐞𝐝 significantly. 𝐌𝐮𝐥𝐭𝐢𝐩𝐥𝐞 𝐫𝐞𝐚𝐬𝐨𝐧𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐝𝐫𝐨𝐩: 🔶𝐖𝐞𝐚𝐤𝐞𝐧𝐞𝐝 𝐃𝐞𝐦𝐚𝐧𝐝: Post-Covid demand for APIs has decreased. 🔶𝐁𝐫𝐨𝐤𝐞𝐧 𝐂𝐡𝐢𝐧𝐞𝐬𝐞 𝐂𝐚𝐫𝐭𝐞𝐥𝐬: Increased competition due to the dismantling of Chinese cartels regulating API prices. 🔶𝐈𝐧𝐝𝐢𝐚'𝐬 𝐒𝐞𝐥𝐟-𝐑𝐞𝐥𝐢𝐚𝐧𝐜𝐞: A rise in domestic API production has lessened dependence on China. 🔶𝐎𝐯𝐞𝐫𝐜𝐚𝐩𝐚𝐜𝐢𝐭𝐲 𝐢𝐧 𝐀𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐢𝐨𝐧: Increased production capacity in anticipation of higher demand that never materialized. #pharma #healthcare #Api #india #drugpricing #pharmaceuticalindustry
-
-
We are excited to release the 2nd edition of Rubix Industry Insights, our monthly feature on key Indian industries. This edition is on the Pharmaceutical Industry, which is experiencing growth, fuelled by a surge in domestic demand and a booming export market. Our latest Rubix Industry Insights report delves into the key drivers propelling this double-digit growth. Uncover the secrets behind India's Pharma Success Story: - Domestic Demand on Fire: Explore how rising healthcare awareness and a growing population are driving a consumption boom within India. - Global Powerhouse in the Making: Is India the next "Pharmacy of the World"? Our report investigates India's impressive 60% share of the global vaccine market. - Beyond Generics: While generics are a major strength, we analyze the potential for India to become a leader in complex and specialty pharmaceuticals. - Navigating the Landscape: Gain insights into both the exciting opportunities and the challenges facing the Indian pharmaceutical sector, empowering you to make informed decisions. What’s more, this report has been featured in all print editions of Financial Express (India) You can check out the previous Rubix Industry Insights: Agrochemicals here: https://lnkd.in/dM4XrTcE Stay tuned for more industry insights and updates from Rubix Data Sciences! . . . . #RubixIndustryInsights #Insights #IndianIndustries #PharmaceuticalIndustry #PharmaIndustry #Pharma #Pharmacy #Agrochemicals
-
India's Pharma Industry Soaring! Our latest Rubix Industry Insights explores why India has become the “Pharmacy of the World”. Read more for insights on domestic growth, exports & future potential.#RubixIndustryInsights #Insights #IndianIndustries #PharmaceuticalIndustry #PharmaIndustry #Pharma
We are excited to release the 2nd edition of Rubix Industry Insights, our monthly feature on key Indian industries. This edition is on the Pharmaceutical Industry, which is experiencing growth, fuelled by a surge in domestic demand and a booming export market. Our latest Rubix Industry Insights report delves into the key drivers propelling this double-digit growth. Uncover the secrets behind India's Pharma Success Story: - Domestic Demand on Fire: Explore how rising healthcare awareness and a growing population are driving a consumption boom within India. - Global Powerhouse in the Making: Is India the next "Pharmacy of the World"? Our report investigates India's impressive 60% share of the global vaccine market. - Beyond Generics: While generics are a major strength, we analyze the potential for India to become a leader in complex and specialty pharmaceuticals. - Navigating the Landscape: Gain insights into both the exciting opportunities and the challenges facing the Indian pharmaceutical sector, empowering you to make informed decisions. What’s more, this report has been featured in all print editions of Financial Express (India) You can check out the previous Rubix Industry Insights: Agrochemicals here: https://lnkd.in/dM4XrTcE Stay tuned for more industry insights and updates from Rubix Data Sciences! . . . . #RubixIndustryInsights #Insights #IndianIndustries #PharmaceuticalIndustry #PharmaIndustry #Pharma #Pharmacy #Agrochemicals
-
Digital Media Sales Consultant | Expanding Revenue Horizons | Where Brand Meet Digital Opportunities.
India's Pharma Industry Soaring! Our latest Rubix Industry Insights explores why India has become the “Pharmacy of the World”. Read more for insights on domestic growth, exports & future potential. #RubixIndustryInsights #Insights #IndianIndustries #PharmaceuticalIndustry #PharmaIndustry #Pharma
We are excited to release the 2nd edition of Rubix Industry Insights, our monthly feature on key Indian industries. This edition is on the Pharmaceutical Industry, which is experiencing growth, fuelled by a surge in domestic demand and a booming export market. Our latest Rubix Industry Insights report delves into the key drivers propelling this double-digit growth. Uncover the secrets behind India's Pharma Success Story: - Domestic Demand on Fire: Explore how rising healthcare awareness and a growing population are driving a consumption boom within India. - Global Powerhouse in the Making: Is India the next "Pharmacy of the World"? Our report investigates India's impressive 60% share of the global vaccine market. - Beyond Generics: While generics are a major strength, we analyze the potential for India to become a leader in complex and specialty pharmaceuticals. - Navigating the Landscape: Gain insights into both the exciting opportunities and the challenges facing the Indian pharmaceutical sector, empowering you to make informed decisions. What’s more, this report has been featured in all print editions of Financial Express (India) You can check out the previous Rubix Industry Insights: Agrochemicals here: https://lnkd.in/dM4XrTcE Stay tuned for more industry insights and updates from Rubix Data Sciences! . . . . #RubixIndustryInsights #Insights #IndianIndustries #PharmaceuticalIndustry #PharmaIndustry #Pharma #Pharmacy #Agrochemicals
